Latest Als News

Paterson Resources has reported promising geochemical test results from its Grace Gold Project, indicating high gold recoveries using conventional cyanide leach methods. These findings support the project's potential for efficient gold extraction and resource upgrading.

Blaze Minerals completed a 1,548m diamond drilling campaign at its Ntungamo Project in Uganda, targeting two pegmatite bodies, while assays from its Mityana Project returned no significant results. The company also secured $1.25 million in capital raising to support ongoing exploration.

White Cliff Minerals has reported impressive first assay results from its maiden drilling campaign at the Rae Copper Project, revealing significant high-grade copper intersections that validate the project's potential.

Asian Battery Metals PLC has completed an oversubscribed A$3.96 million capital raise, fully funding its expanded 2025 exploration program focused on the promising Oval Cu-Ni-PGE discovery in Mongolia. Phase 3 drilling is underway, targeting deeper and along-strike extensions, with initial assay results expected in May.

Solis Minerals has raised A$4.5 million to advance drilling at its copper-rich projects in southern Peru, confirming promising new copper-gold targets and appointing a seasoned CEO to lead exploration efforts.

Metal Bank Limited has reported a substantial 73% increase in its Livingstone Gold Resource in Western Australia, while progressing exploration and development initiatives across Australia, Jordan, and Saudi Arabia, supported by a $275k Queensland government grant for graphite.

Lodestar Minerals has wrapped up its inaugural 16-hole RC drilling campaign at the Darwin IOCG project in northern Chile, targeting high-grade copper and gold mineralisation. Assay results are eagerly awaited, with some samples fast-tracked for early analysis.

Neurizon Therapeutics reported a sharp rise in half-year losses to $7.28 million but marked significant progress with its lead drug NUZ-001 entering a major ALS clinical trial and securing critical regulatory designations.

EV Resources Limited has responded to ASX inquiries confirming the material impact of China's molybdenum export controls and recent high-grade antimony assay results on its securities.

Neurizon Therapeutics received FDA guidance on its IND application for NUZ-001, with a single request for additional animal exposure data but no safety concerns flagged. The company is actively addressing the FDA’s request while evaluating impacts on its ALS trial timeline.

Orora reports a 24.6% rise in underlying EBIT to $120.8 million for H1 FY25, driven by the Saverglass acquisition and portfolio simplification, while navigating operational challenges and market headwinds.

Solis Minerals has confirmed extensive copper porphyry mineralisation at its Cinto Project in Peru, revealing promising assay results and advancing towards drilling in late 2025.